TSE:6869Medical Equipment
How Investors Are Reacting To Sysmex (TSE:6869) Upgrading Earnings Guidance On Americas Demand And Weaker Yen
Earlier in August 2026, Sysmex Corporation raised its consolidated earnings guidance for the six months to September 30, 2026 and the full year to March 31, 2027, lifting expected net sales to ¥265,000 million and operating profit to ¥25,000 million for the half year, and to ¥545,000 million and ¥60,000 million respectively for the full year.
The upgrade was driven mainly by stronger-than-expected hematology instrument sales in the Americas and a weaker yen, highlighting how regional demand...